Ticker

OPTI.LSE

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators in the United Kingdom, the United States, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; CholBiome, a food supplement for reducing cholesterol and blood pressure; LPGOS, a galactooligosaccharide that is used in food products and applications, which helps reduce cardiovascular risk factors and enhance health; and Sweetbiotix, a low calorie sweetener for food and beverages. The company's products prevent and manage chronic lifestyle disorders, including obesity, hypercholesterolemia, and diabetes. The company was formerly known as Ducat Ventures PLC and changed its name to OptiBiotix Health Plc in August 2014. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.